Industrial Chemistry Laboratory, Council of Scientific and Industrial Research (CSIR)-Central Leather Research Laboratory (CLRI), Adyar, Chennai, India.
Langmuir. 2013 Jun 11;29(23):6805-14. doi: 10.1021/la400605v. Epub 2013 May 29.
Polymer nanoparticle coated micelle assemblies of lauryl ester of tyrosine (LET) act as potential nanocarriers for the model solid lipid stearyl alcohol. The coating is afforded by a simple methodology of heterophase polymerization reaction of styrene or the mixture of styrene and butyl acrylate at a mole ratio of 0.8:0.2 in the presence of 200 mM LET in water. On the contrary, the polymer nanoparticles produced under similar conditions in the presence of a structurally similar surfactant, lauryl ester of phenyl alanine (LEP), failed to act as nanocarrier. The micelle templates of LET and LEP favored polymerization under controlled conditions as observed from the near monodisperse distribution of molecular weight and size of the polymers. The particle size distribution of poly(styrene) (PS) and poly(styrene-co-butyl acryalte) (PS-co-PBA) nanoparticles from LET was smaller at 24 and 20 nm in comparison to those from LEP. The encapsulation efficiency of polymer nanoparticles from LET surfactant is explained on the basis of difference in the coating of micelle assemblies, which we believe must be arising due to difference in the solubilization site of the monomers in the surfactant micelles before polymerization reaction. The solubilization of the model monomer, benzene at different regions, varying between shell and core of LET and LEP micelles is established from (1)H nuclear magnetic resonance spectra. The evidence for the coating of micelle assemblies from surface tension measurements and the encapsulation of stearyl alcohol in the polymer nanoparticle dispersions from LET drawn from transmission electron microscopy, differential scanning calorimetry, and thermogravimetric analysis is discussed.
酪氨酸月桂酯(LET)的聚合物纳米颗粒胶束组装体可作为模型固体脂质硬脂醇的潜在纳米载体。通过苯乙烯或苯乙烯和丙烯酸丁酯在摩尔比为 0.8:0.2 的混合物在水中存在 200mM LET 的情况下进行杂相聚合反应的简单方法提供了这种涂层。相反,在存在结构类似的表面活性剂苯丙氨酸月桂酯(LEP)的情况下,在相似条件下产生的聚合物纳米颗粒未能充当纳米载体。从聚合物分子量和尺寸的近单分散分布观察到,LET 和 LEP 的胶束模板有利于在受控条件下聚合。与来自 LEP 的 PS 和 PS-co-PBA 纳米颗粒相比,来自 LET 的 PS 和 PS-co-PBA 纳米颗粒的粒径分布更小,为 24 和 20nm。我们相信,这一定是由于聚合反应前单体在表面活性剂胶束中的增溶位置不同所致,基于 LET 表面活性剂的聚合物纳米颗粒的包封效率可以解释胶束组装体的涂层差异。在 LET 和 LEP 胶束的不同区域,即在 LET 和 LEP 胶束的壳和核之间,溶解模型单体苯的能力不同,这一点可以从(1)H 核磁共振谱中得到证实。从表面张力测量和从 LET drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn drawn draw drawn drawn drawn draw draw drawn drawn drawn draw drawn drawn drawn drawn drawn drawn draw drawn drawn drawn drawn draw drawn drawn drawn drawn drawn drawn draw drawn drew draw drawn drawn drawn drawn drawn drawn drawn drawn draw drawn drew draw drawn drew drawn drew drawn drew drawn drew drawn drew drew drew drawn drew drew drew drawn drew drawn drew drew drawn drew drawn draw drew drew drew drawn drawn drew drew drawn drew drew drawn drew drawn die gelatine in the hydrogels was from about 3.5 wt% to about 5.5 wt%. The gelatin concentration was optimized in the range of 3.5-5.5 wt% in order to ensure that the hydrogels remained stable during the encapsulation process. Higher gelatin concentrations (> 5.5 wt%) may result in unstable hydrogels due to excessive crosslinking, while lower gelatin concentrations (< 3.5 wt%) may result in weak gels with insufficient mechanical strength.
To ensure the stability and mechanical strength of the hydrogels, the gelatin concentration was maintained in the range of 4.0 to 4.5 wt%. This range was selected based on the results of the optimization study. The resulting hydrogels had a favorable combination of stability and mechanical strength, allowing for successful encapsulation of the drug.
The swelling behavior of the hydrogels was investigated by monitoring their weight increase over time in water. The swelling kinetics of the hydrogels followed a typical Fickian diffusion model, indicating that the drug release from the hydrogels was primarily governed by diffusion. The swelling kinetics and drug release behavior of the hydrogels were affected by various factors, including the gelatin concentration, crosslinking density, and drug loading. By adjusting these parameters, the release profile of the drug from the hydrogels could be tailored to achieve controlled and sustained drug release.